newsfilter
← Latest News
PR Newswire·

CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition

SEATTLE, Dec. 11, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at the 64th American Society of